Document is current
Any future updates will be listed below
-
Authors
Fazeli, Elnaz
Child, Daniel D.
Bucks, Stephanie A.
Stovarsky, Miki
Edwards, Gabrielle
Rose, Shannon E.
Yu, Chang-En
Latimer, Caitlin
Kitago, Yu
Bird, Thomas
Jayadev, Suman
Andersen, Olav M.
Young, Jessica E. https://orcid.org/0000-0003-2106-0339
-
Funding
Funding for this research was provided by:
National Institute on Aging (AG062148)
National Institute on Aging (AG059841)
National Institute on Aging (AG052354-06A1)
National Institute on Aging (AG05136)
Alzheimer's Association (23AARG1022491)
Alzheimer's Association (ADSF-21-831378-C)
Novo Nordisk (NNF20OC0064162)
- License Information
-
More Information
Article History
Received: 16 August 2023
Revised: 11 November 2023
Accepted: 16 December 2023
First Online: 20 January 2024
Declarations
:
: O. M. A. is a consultant for Retromer Therapeutics and has equity. The other authors report no competing interests.
